United Healthcare has recently announced a policy change. Effective January 1, 2023, UHC will no longer cover home- and self-administered subcutaneous allergen immunotherapy. The AAOA, in conjunction with AAOHNS, is working to try to reverse this policy change. In the meantime,…
Allergy Comments on 2019 Proposed PFS
The Advocacy Council of the American College of Allergy, Asthma and Immunology (ACAAI) together with its sponsoring organization, the ACAAI, the American Academy of Allergy, Asthma and Immunology (AAAAI), and the American Academy of Otolaryngic Allergy (AAOA) submitted comments on the proposed changes to the physician fee schedule rule for 2019 as published in the July 27, 2018 Federal Register.
Our comments focus on four issues: (1) the cost of venom antigens used in treating allergies to stinging insects (CPT Codes 95145-95149); (2) the proposal to reduce the supply cost for inhalant antigens used in allergen immunotherapy (CPT Codes 95144 and 95165); (3) the proposed change in the allergy/immunology indirect practice cost index (IPCI) resulting from the consolidation of evaluation and management (E&M) office visit codes and the creation of a 2 separate “specialty” for E&M office visits; and (4) the multiple procedure payment reduction (MPPR) policy.
Comments were successfully uploaded to the CMS site. View the final document here.
